Use of Long-Acting Lipoglycopeptide Antibiotics—Beyond Convenience

This Clinical Insights summarizes the pharmacological characteristics of dalbavancin and oritavancin and evaluates the clinical evidence supporting their use in infections beyond acute bacterial skin and skin structure infections for general internal medicine clinicians.

Authors

Institutions

Publication Details

Journal
JAMA Internal Medicine
Published
2026-04-27
DOI
https://doi.org/10.1001/jamainternmed.2026.0977
Primary Topic
Antimicrobial Resistance in Staphylococcus
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Use of Long-Acting Lipoglycopeptide Antibiotics—Beyond Convenience

Raneem H. Pallotta, Emily S. Spivak
JAMA Internal Medicine
Antimicrobial Resistance in Staphylococcus
article

Use of Long-Acting Lipoglycopeptide Antibiotics—Beyond Convenience

Raneem H. Pallotta, Emily S. Spivak
article en

Abstract

This Clinical Insights summarizes the pharmacological characteristics of dalbavancin and oritavancin and evaluates the clinical evidence supporting their use in infections beyond acute bacterial skin and skin structure infections for general internal medicine clinicians.

JAMA Internal Medicine
University of Utah (US)
Openalex Percentile: Top 5%
Antimicrobial Resistance in Staphylococcus
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.